Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Frontiers in Physiology publish data with C21 on pulmonary fibrosis

Vicore Pharma Holding (publ) (ticker:VICO) can today announce that preclinical data with C21 demonstrating good results has been accepted for publication.A recently accepted manuscript entitled “The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury” (Rathinasabapathy et al., Front Physiol 2018, 9:180. doi: 10.3389/fphys.2018.00180) reports about the anti-fibrotic effect of Vicore Pharma’s lead compound, C21, in one of the standard preclinical models

Catella Asset Management Iberia exceeds EUR 200 million in assets under management

Catella’s Iberian real estate asset management platform, Catella Asset Management Iberia (Catella AM), has exceeded EUR 200 million in assets under management, strengthening its presence in value-add assets and alternative investments. Catella AM is part of Catella’s Property Investment Management business area, with in total EUR 5,6 billion in assets under management. Following the acquisition of the Planetocio shopping and leisure centre in Madrid, Catella AM has successfully completed its tenth transaction in Spain, where it operates in the residential, retail and student housing sectors.

Newsletter

Brain tumor therapy – a new cancer indication for HAMLET PharmaThe prognosis of malignant brain tumors remains dismal, even though the development of effective therapies is a prioritized area both in academia and industry. Despite an aggressive treatment protocol consisting of surgery, radiation and chemotherapy, the median survival is only about 15 months. The failure of current therapies is thought to reflect the intrinsic drug and radiation resistance of the tumor cells, the toxicity of the drugs for normal brain tissue, and poor drug penetration from the blood stream through the blood-

Wärtsilä and Crowley extend maintenance agreement for 11 articulated tug barges

Wärtsilä Corporation, Press release, 21 March 2018 at 10 a.m. EETThe technology group Wärtsilä and Crowley Petroleum Services are continuing their co-operation by extending and expanding their maintenance agreement for 11 articulated tug barges (ATBs) owned and operated by US-based Crowley. An ATB has a hinged connection system that allows a powerful ocean-going tug to connect to a notch in the stern of the barge, which enables the tug to propel and maneuver the barge.   The agreement, signed in December 2017, extends the original contract term from 2019 to 2023, and covers the

RISE explores opportunities for the Swedish process industry to benefit from electrofuels

In a newly launched research project, RISE, together with Södra, AkzoNobel Specialty Chemicals and BillerudKorsnäs, with the support of the Swedish Energy Agency, investigates the opportunities for the Swedish pulp, chemical and paper industry to increase the production of renewable fuels while taking a more active role in the electricity market by producing so-called electrofuels. Sweden aims to have an electricity production that is 100 percent renewable in 2040. The goal is to be achieved by mainly expanding the production of solar and wind power, which are both weather-dependent

Valmet has published restated figures for 2017 and guidance for 2018

Valmet Oyj's stock exchange release on March 21, 2018 at 10:00 a.m. EET Valmet Oyj's consolidated interim and full year 2017 financials have been restated due to the adoption of IFRS 15 - Revenue from Contracts, as of January 1, 2018. The standard provides a new basis for revenue and cost of sales recognition. Valmet's restated financials for 2017 provide comparatives for quarterly result releases for year 2018. The restated financial information has not been audited. The cumulative effect of applying IFRS 15 has reduced net sales by EUR 100 million, Comparable EBITA by EUR 8 million

Elkem ASA – Expiry of bookbuilding/application period

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OF AMERICA AND THE DISTRICT OF COLUMBIA) (THE "UNITED STATES"), AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Oslo, 21 March 2018. Elkem ASA ("Elkem" or the "Company" with OSE ticker code: "ELK"). Reference is made to the announcements regarding the launch on the initial public offering of shares of Elkem (the "IPO" or the "Offering")

#18-489 Listing of Knock out warrant issued by Vontobel Financial Products GmbH

As from March 22, 2018, 1 Knock out warrant issued by Vontobel Financial Products GmbH will be listed on ETP Finland and will be included on the list for Knock-Outs. The instrument will be registered at Euroclear Finland Oy.Issuer: Vontobel Financial Products GmbH Type of security: Knock out warrant, open ended Execution: Automatic cash settlement Term: As from March 22, 2018 and forward or until time for knock out event Market Maker: Bank Vontobel Europe AG Underlying: DAX 30 Index Current values of strike and barrier can be found at: [ NGM Market Data Web -

Viking Line and Matkapojat will start a broader co-operation with new regularly-scheduled bus connections from several areas in Finland

Viking Line and Matkapojat have increased their collaboration to offer bus connections to Viking XPRS on the Helsinki–Tallinn-route. The bus service is provided to and from a significant number of municipalities. The companies originally joined forces in the 1970s when Matkapojat began to transport customers from remote areas to the ports in Turku, Naantali and Helsinki. Now the expanded service will provide thousands of customers, from more than 700 places around Finland, with an easy and convenient way to reach the ports for day cruises to Tallinn, spa trips to Estonia and hotel holidays

Solteq Plc: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 5

Solteq Plc Stock Exchange Bulletin 21.3.2018 at 9.30 am  Solteq Plc has on 21.3.2018, received a notification under Chapter 9, Section 5 of the Securities Market Act, according to which the holding of Sentica Buyout III GP Oy in Solteq Plc’s shares and votes has fallen below 25 percent. On 21.3.2018, Sentica Buyout III GP Oy’s total holding of shares amounted to 24,87 percent of Solteq Plc’s shares and votes. According to the notification, the change in total position is due to registration of new shares into trade register.  Total position of Sentica Buyout III GP Oy subject to the

IAR Systems acquires Secure Thingz

Uppsala, Sweden—March 21, 2018—The Swedish company IAR Systems Group AB (“IAR Systems”) has today entered into a share sale and purchase agreement to acquire 100 percent of the shares in Secure Thingz, Inc. (“Secure Thingz”), a provider of advanced security solutions for embedded systems in the Internet of Things (IoT). With the acquisition, IAR Systems secures its position as a frontrunner in offering solutions for security in embedded systems. The transactionPreviously, IAR Systems has acquired approximately 20 percent of the shares in Secure Thingz. With today’s acquisition, IAR

Matt Nitzberg named Chief Client Officer at Nepa US

Industry veteran joins to help bring company’s innovative consumer science driven research to US-based Consumer Packaged Goods, Retail Clients.Matt Nitzberg has joined Nepa, a leading provider of customer experience and marketing optimization solutions, to work with the company’s growing roster of U.S.-based consumer packaged goods (CPG) and retail clients. “Retailers and CPG companies need new ways to understand their shoppers, prioritize their investments, and move swiftly to action,” said Ken Peterson, Managing Director, Nepa US. “Matt understands their business challenges, from C-

Receipt of payment for KRI oil exports

21 March 2018 Genel Energy plc Receipt of payment for KRI oil exports Genel Energy plc ('Genel') announces that the Taq Taq partners have received a gross payment of $9.23 million from the Kurdistan Regional Government ('KRG') for oil sales during December 2017. This payment includes a downwards adjustment of $1.54 million, reconciling previous payments with PSC entitlement for the months of August to December 2017. Genel's net share of the payment is $5.08 million. -ends- For further information, please contact: Genel Energy      +44 20 7659 5100

Alma Media to combine the Alma News & Life and the Alma Regions business segments; Kari Kivelä to head the new segment

Alma Media Corporation        Stock Exchange Release                      21 March 2018 at 9.00 a.m. (EET) ALMA MEDIA TO COMBINE THE ALMA NEWS & LIFE AND THE ALMA REGIONS BUSINESS SEGMENTS; KARI KIVELÄ TO HEAD THE NEW SEGMENT Alma Media will combine the Alma News & Life business segment, which produces news and lifestyle services, and Alma Regions business segment, which focuses on regional and local media business, from 1 April 2018. After the business segment combination, Alma Media will comprise three business segments: Alma Markets, focusing on digital marketplaces and the

Gränges Capital Markets Day 2018

·  Review of the company's goals and strategy for 2020 ·  Good start of the year with strong customer demand in all markets ·  A clear growth agenda for the coming years focusing on innovation, expansion and sustainability Gränges holds its Capital Markets Day in Stockholm on Wednesday March 21. The company presents an overview of its strategy and goals for 2020, and what the company has achieved so far. "Our focus is on continuing to develop Gränges as a leading niche player in the aluminium industry. Since 2014, we have delivered our financial and operational targets, which

Medals of War hard launch started on Android

Nitro Games, a leading Finnish developer and publisher of mobile games, announced it’s latest game “Medals of War” is now available on Android on the Google Play Store in 70 countries in 15 languages. “This release signals the beginning of our hard launch of Medals of War on Android. We’ve had the game previously available for testing in Google Play Open Beta. Google has supported us with Early Access –featuring during the Open Beta stage and we’re now happy moving forward with this launch by releasing the game for a wider audience.” says Jussi Tähtinen, CEO & Co-Founder, Nitro

New shares in Solteq Plc registered into the trade register

Solteq Plc Stock Exchange Bulletin 21.3.2018 at 9.00 am      Solteq Plc directed a share issue, totaling to 628,930 shares, to the shareholders of TM United A/S as a part of the company acquisition on 15 January 2018.        The new shares have been registered into trade register today. After the changes the total number of the shares is 19,306,527.      The new shares will be publicly traded as of 22 March 2018.      Solteq Plc      Further information    Olli Väätäinen, CEO  tel. +358 50 5578 111  e-mail olli.vaatainen@solteq.com       Antti

Fortum to support Uniper dividend proposal

FORTUM CORPORATION STOCK EXCHANGE RELEASE 21 MARCH 2018 9.00 EET  On 26 February 2018, Uniper’s management board proposed to have a dividend of EUR 0.74 cents per share for the financial year 2017 distributed by resolution of the Ordinary Annual General Meeting (AGM) scheduled to be held on 6 June 2018. Following such proposal, Fortum Corporation and E.ON SE have agreed that, in the event that Fortum’s public takeover offer to all Uniper shareholders closes after Uniper’s AGM, E.ON shall be free to vote for the dividend in the amount of EUR 0.74, or any other amount higher than EUR 0.69

Notice to the annual general meeting in Bonava AB (publ)

Welcome to Bonava AB's (publ) ("Bonava") annual general meeting on Wednesday 25 April 2018 at 3 pm, at Hotel Rival, Mariatorget 3 in Stockholm. Registration at the general meeting will open at 2.00 pm.Participation To be entitled to participate at the annual general meeting, shareholder must: · be listed in the shareholders' register maintained by Euroclear Sweden AB on Thursday, 19 April 2018, · give notice of his/her/its intention to attend the general meeting no later than on Thursday, 19 April 2018, and inform about the number of advisors, if any, who will accompany the

Sobi™ launches Ravicti® in Europe and advances the care for patients with Urea Cycle Disorders

Swedish Orphan Biovitrum AB (publ) (Sobi™)  announces that the company has gained reimbursement for Ravicti®, a new therapy option for the treatment of patients with Urea Cycle Disorders (UCDs) in several EU member states and EEA-countries. Sweden, Denmark, Austria and Germany are the first countries to launch, followed by UK, Spain and the Netherlands. “We are very pleased that Ravicti is gaining reimbursement in countries across Europe for patients with Urea Cycle Disorders”, said Norbert Oppitz, Head of Specialty Care at Sobi. “The reimbursement enables us to

The American Journal of Transplantation publishes results from Hansa Medical's first Phase II study with IdeS

Hansa Medical AB (Nasdaq Stockholm: HMED), a biopharmaceutical company developing novel immunomodulatory enzymes, today announced that clinical results from Hansa Medical’s first Phase II study (ClinicalTrials.gov Identifier: NCT02224820) with lead candidate IdeS (INN: Imlifidase) will be published today by the American Journal of Transplantation (AJT), the monthly peer reviewed medical journal published by the American Society of Transplant Surgeons and the American Society of Transplantation."The publication in the AJT describes the design and results from our very first clinical study in

Notice of the Annual General Meeting in Wihlborgs Fastigheter AB (publ)

The shareholders of Wihlborgs Fastigheter AB (publ) are hereby invited to attend the Annual General Meeting at 4:00 p.m. on Wednesday, 25 April 2018, at Slagthuset, Jörgen Kocksgatan 7 A in Malmö.Notification  Shareholders wishing to participate in the Annual General Meeting must: ·         be entered in the register of shareholders maintained by Euroclear Sweden AB as of Thursday, 19 April 2018; and ·         give notice of their intention to attend not later than 4:00 p.m. on Thursday, 19 April 2018. Notification of participation in the meeting may be given in any of the

BONESUPPORT™ – Positive clinical data for CERAMENT® G in infection management presented at BLRS 2018

Lund, Sweden, 08.00 CET, 21 March 2018 – BONESUPPORT™, an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT® platform announces that three papers based on the successful use of CERAMENT® G to treat bone infections were presented at the British Limb Reconstruction Society (BLRS) Meeting 2018, which took place from the 15-16th March in Southampton.  One of the papers, entitled ‘The choice of local antibiotic carrier significantly affects outcome in treatment

Kesko's share-based commitment and incentive plans for 2018–2021

Kesko Corporation's Board of Directors has decided that the target group for the 2018–2019 performance period of Kesko’s performance and share based commitment and incentive plan will comprise approximately 130 members of Kesko’s management and other specified key persons. The Board has also confirmed the criteria for 2018 for both the 2017–2020 plan initiated in 2017 and the 2018–2021 plan. The Board has also decided to initiate a restricted share-based commitment and incentive plan for 2018–2020.  Kesko’s share-based commitment and incentive plan comprises two share-based plans, which

There are no items matching the current filter
There are no more items matching the current filter
Back to top